Zhejiang Lihui Import Co.,Ltd.
Sales & Support:
 |
| Place of Origin: | China |
| Brand Name: | LiHui |
| Certification: | Hplc ISO9001 |
| Model Number: | 144060-53-7 |
| Minimum Order Quantity: | 100g |
|---|---|
| Price: | Negotiated |
| Packaging Details: | Foil Bag |
| Delivery Time: | 3-7days after received payment |
| Payment Terms: | T/T, Western Union, MoneyGram |
| Supply Ability: | 5000Kg Per Month |
| CAS: | 144060-53-7 | Color Or Appearance: | White Crystalline Powder |
|---|---|---|---|
| Packing Specification: | Aluminum Foil Bag Or Aluminum Tin 25 Kg/barrel | Execution Standard: | USP42 |
| Product Purity: | 99% | The Product Level: | Pharmaceutical Grade |
| Molecular Formula: | C16H16N2O3S | ||
| High Light: | Cas 144060-53-7,144060-53-7 Allopurinol Febuxostat,Allopurinol Febuxostat For Gout Treatment |
||
High Quality Febuxostat API Powder Cas No 144060-53-7 For Gout Treatment
Febuxostat is a new generation of xanthine oxidase inhibitor developed by Japanese company. It is used in the treatment of gout. Its structure is totally different from that of xanthine oxidase inhibitor developed 40 years ago. It is a new and efficient selective inhibitor of non purine xanthine oxidase. Xanthine oxidase is the key enzyme to promote the production of uric acid. Febuxostat can reduce the level of chemical Book uric acid in the blood of gout patients with hyperuricemia. The clinical research shows that the product is safe and effective. The product is metabolized through the liver and does not depend on renal excretion. Therefore, it is not necessary to reduce the dosage of febuxostat in patients with moderate to severe hepatorenal insufficiency. The dosage is 40 mg or 80 mg once a day. It is not recommended to treat gout patients without hyperuricemia. In February 2009, the U.S. Food and Drug Administration (FDA) approved febuxostat for the long-term treatment of gout hyperuricemia.
| CAS No. | 144060-53-7 |
| Molecular Formula | C16H16N2O3S |
| LogP | 3.72318 |
| PSA | 111.450 |
| Flash point | 278.3°C |
| Melting point | 238-239°(dec.) |
| Boiling point | 536.6±60.0 °C(Predicted) |
| Density | 1.31g/cm3 |
| Shelf life | 2 Years |
(1) the allopurinol only have inhibition to reduced the XOR, rather than cloth sutent XOR of
oxidation and reduced significantly inhibitory effect, more powerful, durable and its effect in
lowering uric acid;
(2) because allopurinol is a purine analogues, it is inevitable to affect the metabolism of other
enzymes involved in purine and pyridine metabolism.So in allopurinol treatment, you need to
repeat a large dose to maintain a high level of medication.It also leads to serious and even fatal
adverse reactions caused by drug accumulation.Instead of being a non-purine XOR inhibitor, it
has better security.
| Product Name | CAS No. | Product Name | CAS No. |
| Lufenuron | 103055-07-8 | Toltrazuril | 69004-03-1 |
| Nitenpyram | 120738-89-8 | Praziquantel/Biltricide | 55268-74-1 |
| Fenbendazole | 43210-67-9 | Tetramisole Hcl | 5086-74-8 |
| Levamisole | 14769-73-4 | Ponazuril | 9004-4-2 |
| Diclazuril | 101831-37-2 | Florfenicol | 73231-34-2 |
| Ivermectin | 70288-86-7 | Enrofloxacin Hcl | 112732-17-9 |
| Albendazole | 54965-21-8 | Mebendazole | 31431-39-7 |
Contact Person: sales
Tel: +8613777515435
CAS 112809-51-5 Letrozole Femara For Infertility Treatment USP42 Standard
82640-04-8 Active Pharmaceutical Ingredient API Raloxifene Hydrochloride HCL
Desloratadine Active Pharmaceutical Ingredient API 100643-71-8 For Relief Allergic Rhinitis
Antifungal Antibiotic API Miconazole Nitrate For Yeast Infecti 22832-87-7
C14H10Cl2NNaO2 Antibiotic API 15307-79-6 Diclofenac Sodium For Headache
T4 Clenbuterol Weight Loss Powder CAS 21898-19-1 White Crystalline Powder
846589-98-8 Lorcaserin Hydrochloride Steroids Fat Loss
99% Purity Follistatin 344 Bodybuilding Peptide Raw Powder Strong Effect 96829-58-2
